| pubmed-article:7536629 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7536629 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:7536629 | lifeskim:mentions | umls-concept:C0699040 | lld:lifeskim |
| pubmed-article:7536629 | lifeskim:mentions | umls-concept:C0524637 | lld:lifeskim |
| pubmed-article:7536629 | lifeskim:mentions | umls-concept:C0003342 | lld:lifeskim |
| pubmed-article:7536629 | pubmed:dateCreated | 1995-5-19 | lld:pubmed |
| pubmed-article:7536629 | pubmed:abstractText | There is now a very good understanding of the way in which epitope peptides are generated from virus proteins and how the peptides bind to the class I MHC molecules. This gives a framework in which to analyse the potentially protective cytotoxic T lymphocyte response in human immunodeficiency virus infection. A detailed understanding of the specificity of the responding T cells, the clonality of these T cells and the effects of virus variation on the CTL gives a possible explanation for the ultimate failure of the CTL response to control this virus infection. | lld:pubmed |
| pubmed-article:7536629 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7536629 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536629 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7536629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536629 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7536629 | pubmed:issn | 0261-2429 | lld:pubmed |
| pubmed-article:7536629 | pubmed:author | pubmed-author:McMichaelAA | lld:pubmed |
| pubmed-article:7536629 | pubmed:author | pubmed-author:GotchFF | lld:pubmed |
| pubmed-article:7536629 | pubmed:author | pubmed-author:MossPP | lld:pubmed |
| pubmed-article:7536629 | pubmed:author | pubmed-author:KlenermanPP | lld:pubmed |
| pubmed-article:7536629 | pubmed:author | pubmed-author:Rowland-Jones... | lld:pubmed |
| pubmed-article:7536629 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7536629 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:7536629 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7536629 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7536629 | pubmed:pagination | 51-62 | lld:pubmed |
| pubmed-article:7536629 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:meshHeading | pubmed-meshheading:7536629-... | lld:pubmed |
| pubmed-article:7536629 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7536629 | pubmed:articleTitle | Recognition of viral antigens at the cell surface. | lld:pubmed |
| pubmed-article:7536629 | pubmed:affiliation | Institute of Molecular Medicine, John Radcliffe Hospital, Oxford. | lld:pubmed |
| pubmed-article:7536629 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7536629 | pubmed:publicationType | Review | lld:pubmed |
